Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer discovery

Showing results (371-380 of 4,677) with videos related to

Pageof 468
Sort By:
Cancer Discovery|February 25, 2015
Next steps for cancer immune therapy
Cancer Discovery|February 26, 2015
First CDK 4/6 Inhibitor Heads to Market
Cancer Discovery|February 28, 2015
Lenvatinib approved for certain thyroid cancers
Cancer Discovery|August 21, 2020
Gilead Buys into Tizona's Anti-HLA-G Strategy
Cancer Discovery|April 3, 2023
Moving Spatially Resolved Multiplexed Protein Profiling toward Clinical OncologyMaryam Pourmaleki, Nicholas D Socci, Travis J Hollmann, et al.
Cancer Discovery|April 3, 2023
Correction: Creating MHC-Restricted Neoantigens with Covalent Inhibitors That Can Be Targeted by Immune Therapy
Cancer Discovery|April 3, 2023
Childhood Cancer Treatment and Clonal HematopoiesisGrace Collord, Sam Behjati
Cancer Discovery|April 24, 2023
Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid LeukemiaChristina Glytsou, Xufeng Chen, Emmanouil Zacharioudakis, et al.
Cancer Discovery|April 26, 2023
Broadening Cancer Screening with WES
Cancer Discovery|April 4, 2023
Q&A: Robert Vonderheide on Immunotherapy Advances
Pageof 468

Showing results (371-380 of 4,677) with videos related to

Sort By:
Pageof 468
Cancer Discovery|February 25, 2015
Next steps for cancer immune therapy
Cancer Discovery|February 26, 2015
First CDK 4/6 Inhibitor Heads to Market
Cancer Discovery|February 28, 2015
Lenvatinib approved for certain thyroid cancers
Cancer Discovery|August 21, 2020
Gilead Buys into Tizona's Anti-HLA-G Strategy
Cancer Discovery|April 3, 2023
Moving Spatially Resolved Multiplexed Protein Profiling toward Clinical OncologyMaryam Pourmaleki, Nicholas D Socci, Travis J Hollmann, et al.
Cancer Discovery|April 3, 2023
Correction: Creating MHC-Restricted Neoantigens with Covalent Inhibitors That Can Be Targeted by Immune Therapy
Cancer Discovery|April 3, 2023
Childhood Cancer Treatment and Clonal HematopoiesisGrace Collord, Sam Behjati
Cancer Discovery|April 24, 2023
Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid LeukemiaChristina Glytsou, Xufeng Chen, Emmanouil Zacharioudakis, et al.
Cancer Discovery|April 26, 2023
Broadening Cancer Screening with WES
Cancer Discovery|April 4, 2023
Q&A: Robert Vonderheide on Immunotherapy Advances
Pageof 468